Date,Contact Name,Company,Email,Sequence Step,Status,Response,Next Action,Notes
2025-02-15,John Travaglini,4Front Capital Partners,john@4frontcapitalpartners.com,1,Draft Pending Approval,,,CEO - High Priority
2025-02-15,Mark Kennedy,4Front Capital Partners,mkennedy@4frontcapitalpartners.com,1,Draft Pending Approval,,,Managing Director - High Priority
2025-02-15,Andreas Schulte,AS Equity Partners,andreas.schulte@as-equitypartners.com,1,Draft Pending Approval,,,Founder & MP - European
2025-02-15,George Lauro,Alteon Capital Partners,george.lauro@alteoncapital.com,1,Draft Pending Approval,,,Managing Partner & CEO
2025-02-15,Nicolas Massard,Abry Partners,nmassard@abry.com,1,Draft Pending Approval,,,Large Boston PE firm
2025-02-15,Tyler Frances,Alpine Investors,tfrances@alpineinvestors.com,1,Draft Pending Approval,,,Services/Software/Healthcare focus
2025-02-15,Michael Dyment,NEXA Capital Partners,michael.j.dyment@nexacapital.com,1,Draft Pending Approval,,,Managing Partner - DC
2025-02-15,Inder Tallur,BelHealth Investment Partners,itallur@belhealth.com,1,Draft Pending Approval,,,Managing Partner - Healthcare
2025-02-15,Brent Beshore,Permanent Equity,b@permanentequity.com,1,Draft Pending Approval,,,CEO/Founder - Unique firm
2025-02-15,Mitch Baruchowitz,Merida Capital Partners,mitch@meridacapital.com,1,Draft Pending Approval,,,Managing Partner - Cannabis PE
